Literature DB >> 27538977

Ovarian cancer: Place your BETs on combination therapy.

David Killock.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27538977     DOI: 10.1038/nrclinonc.2016.130

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Resistance to BET Bromodomain Inhibitors Is Mediated by Kinome Reprogramming in Ovarian Cancer.

Authors:  Alison M Kurimchak; Claude Shelton; Kelly E Duncan; Katherine J Johnson; Jennifer Brown; Shane O'Brien; Rashid Gabbasov; Lauren S Fink; Yuesheng Li; Nicole Lounsbury; Magid Abou-Gharbia; Wayne E Childers; Denise C Connolly; Jonathan Chernoff; Jeffrey R Peterson; James S Duncan
Journal:  Cell Rep       Date:  2016-07-21       Impact factor: 9.423

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.